Investigator's Brochure (IB) Table


Vaccine Name Sort descending Vaccine Company IB Date Risk List Available?
10-1074 Rockefeller University/Mass Biologics September 2020
Ad26.ENVA.01 Crucell Holland BV June 2013
AdC6-HIVgp140, AdC7-HIVgp140, CH505TF/GLA-SE Vaccines - New DAIDS/NIAID/NIH March 2021
AIDSVAX B/E Global Solutions for Infectious Diseases March 2016
ALVAC-HIV (vCP2438) Sanofi Pasteur August 2017
BG505 SOSIP.664 gp140 DAIDS/NIAID/NIH October 2019
Bivalent Subtype C gp120/MF59 and Bivalent Subtype C gp120/AS01B GlaxoSmithKline July 2016
CH505 TF chTrimer DAIDS/NIAID/NIH November 2020
CH505TF gp120 Transient DAIDS/NIAID/NIH December 2018
CMV-MVA Triplex City of Hope National Medical Center March 2020
EnvSeq-1 and EnvSeq-2 - New DAIDS/NIAID/NIH June 2021
GLA-SE Infectious Disease Research Institute (IDRI) April 2019
Hepatitis B Vaccine Recombinant, Adjuvanted (Heplisav-B) Dynavax Technologies Corporation August 2019
HIV-1 Multiantigen pDNA Vaccine and Human IL-12 pDNA Profectus BioSciences August 2018
MPER-656 Liposomes with Aluminum Hydroxide Suspension DAIDS/NIAID/NIH February 2019
mRNA-1273 - New ModernaTX December 2020
mRNA-1574 Trimer Vaccines - New DAIDS/NIAID/NIH July 2021
MVA-CMDR Walter Reed Army Institute Research (WRAIR) November 2019
N-803 Altor BioScience April 2020
p24CE1/2 multivalent pDNA Vaccine expressing HIV M Group p24 Gag and p55 gag pDNA with IL-12 pDNA NCI/NIAID/NIH November 2017